...
首页> 外文期刊>Journal of nephrology. >Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin
【24h】

Soluble Klotho levels in adult renal transplant recipients are modulated by recombinant human erythropoietin

机译:重组人促红细胞生成素调节成年肾移植受者的可溶性Klotho水平

获取原文
获取原文并翻译 | 示例
           

摘要

Background Data on serum soluble Klotho levels in chronic kidney disease are contradictory and even less is known after renal transplantation. Experimental studies demonstrated that recombinant human erythropoietin (rhEPO) treatment mitigates Klotho reduction caused by renal damage. Therefore, this study aimed to determine serum Klotho levels in a cohort of kidney transplant recipients (KTR) and to evaluate whether rhEPO treatment can modulate, in vivo and in vitro, soluble Klotho.
机译:背景关于慢性肾脏疾病中血清可溶性Klotho水平的数据是相互矛盾的,甚至在肾脏移植后所知甚少。实验研究表明,重组人促红细胞生成素(rhEPO)治疗可减轻肾脏损害引起的Klotho减少。因此,本研究旨在确定一组肾移植受者(KTR)的血清Klotho水平,并评估rhEPO治疗是否可以在体内和体外调节可溶性Klotho。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号